Chemomab Therapeutics Ltd. (NASDAQ: CMMB) will present clinical data from its nebokitug Phase 2 trial in primary sclerosing cholangitis at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE